文献速递颈动脉与弓上血管

无症状颈动脉狭窄患者应谨慎使用经股动脉颈动脉支架

Transfemoral Carotid Artery Stents Should Be Used with Caution in Patients with Asymptomatic Carotid Artery Stenosis.
PubMed 文献 · Ann Vasc Surg · 2018-10-17

基于血管质量倡议(2005-2017)数据,比较无症状颈动脉狭窄患者行颈动脉内膜剥脱术(CEA)与经股动脉颈动脉支架(CAS)的围手术期及2年卒中/死亡风险。重度(60-79%)与极重度(≥80%)狭窄组中,CAS的30天卒中/死亡风险在极重度组显著高于CEA(2.0% vs 1.2%,P<0.001),重度组无显著差异(1.7% vs 1.3%,P=0.17)。2年结局CAS风险仍较高。作者认为药物治疗应作为重度(60-79%)无症状狭窄患者卒中预防的一线方案。

要点

  • 极重度(≥80%)狭窄组CAS的30天卒中/死亡粗发生率显著高于CEA(2.0% vs 1.2%,P<0.001)。
  • 重度(60-79%)狭窄组CAS与CEA的30天卒中/死亡无显著差异(1.7% vs 1.3%,P=0.17)。
  • 多变量分析显示极重度狭窄组CAS的30天卒中/死亡风险仍高于CEA(OR 1.64,95%CI 1.26-2.13)。

核心结论

  • 超过三分之一因无症状颈动脉狭窄行颈动脉血运重建的患者为60-79%狭窄。
  • 较低狭窄程度对CEA或CAS术后30天或2年卒中/死亡均无保护作用。
  • 作者认为对于重度(60-79%)颈动脉狭窄的无症状患者,最佳药物治疗应作为卒中预防的一线方案。

研究设计与样本

  • 回顾性队列研究,纳入血管质量倡议(2005-2017)中所有因无症状颈动脉狭窄行CEA或经股动脉CAS的患者,共53,337例(重度狭窄17,586例,占33.%)。
  • 狭窄程度定义为任何影像学方法记录的最高值;重度为60-79%,极重度为≥80%。
  • 采用单变量和多变量逻辑回归分析30天卒中、卒中/死亡和主要不良心脏事件(MACE);采用Cox比例风险、生命表和Kaplan-Meier估计评估术后2年同侧卒中及卒中/死亡。

主要发现

  • 30天卒中/死亡粗发生率:极重度狭窄组CAS vs CEA为2.0% vs 1.2%(P<0.001);重度狭窄组CAS vs CEA为1.7% vs 1.3%(P=0.17)。
  • MACE在两组中CAS与CEA均无显著差异(P≥0.64)。
  • 多变量分析:极重度狭窄组CAS相比CEA的30天卒中或死亡风险持续较高(OR 1.64,95%CI 1.26-2.13)。
  • CEA患者30天复合卒中/死亡风险在重度与极重度狭窄间相似(OR 1.07,95%CI 0.89-1.28),但重度狭窄组围手术期卒中风险有升高趋势(OR 1.23,95%CI 0.97-1.56)。
  • 2年粗年化发生率:重度狭窄组CAS vs CEA卒中IRR 1.62(95%CI 1.00-2.55)、卒中/死亡IRR 1.53(95%CI 1.11-1.64);极重度狭窄组CAS vs CEA卒中IRR 1.97(95%CI 1.44-2.65)、卒中/死亡IRR 1.51(95%CI 1.34-1.68)(均P≤0.04)。

临床怎么用

  • 作者认为对于重度(60-79%)颈动脉狭窄的无症状患者,最佳药物治疗应作为卒中预防的一线方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Significant national variation exists in defining the degree of stenosis that requires intervention in patients with asymptomatic carotid artery stenosis (ACAS). We aimed to evaluate the risk of perioperative and 2-year stroke and death in ACAS patients undergoing carotid endarterectomy (CEA) and carotid artery stenting (CAS) for severe versus very severe stenosis in a contemporary population. METHODS: All patients undergoing CEA or transfemoral CAS for ACAS in the Vascular Quality Initiative (2005-2017) were included. Degree of stenosis was defined as the highest recorded on any imaging method. Univariable and multivariate logistic regression analyses were performed to assess risk of stroke, stroke/death, and major adverse cardiac events (MACE) at 30 days; and Cox proportional hazard, life tables, and Kaplan-Meier estimates were implemented to evaluate ipsilateral stroke and stroke/death at 2 years postoperatively in patients undergoing CEA versus CAS for severe (60-79%) and very severe (≥80%) stenosis adjusting for baseline characteristics. RESULTS: A total of 53,337 ACAS patients were examined (severe stenosis = 17,586; 33.%), of which 11.5% (n = 6,127) underwent CAS. The crude incidence of 30-day stroke/death was significantly higher for CAS versus CEA in the very severe stenosis group (2.0% vs. 1.2%, P < 0.001), but not in the severe stenosis group (1.7% vs. 1.3%, P = 0.17). MACE was not significantly different for CAS versus CEA in either group (P ≥ 0.64). On multivariable analysis, CAS was associated with a persistently higher risk of 30-day stroke or death compared to CEA in patients with very severe stenosis (odds ratio [OR] 1.64, 95% confidence interval [CI] 1.26-2.13). The 30-day composite stroke/death risk for patients undergoing CEA was similar for severe versus very severe stenosis (OR 1.07, 95% CI 0.89-1.28), but there was a trend toward higher risk of perioperative stroke in the severe stenosis group (OR 1.23, 95% CI 0.97-1.56). Two-year outcomes were similar; the crude annualized incidence rates of stroke and stroke/death were higher for CAS versus CEA in both the severe (stroke: incidence rate ratio [IRR] 1.62, 95% CI 1.00-2.55; stroke/death: IRR 1.53, 95% CI 1.11-1.64) and very severe stenosis (stroke: IRR 1.97, 95% CI 1.44-2.65; stroke/death: IRR 1.51, 95% CI 1.34-1.68) groups (all, P ≤ 0.04). On multivariable Cox proportional hazards analysis, CAS was associated with a higher risk of stroke or death compared to CEA in patients with both severe (hazard ratio [HR] 1.40, 95% CI 1.15-1.70) and very severe stenosis (HR 1.62, 95% CI 1.37-1.90). CONCLUSIONS: More than one-third of patients undergoing carotid revascularization for ACAS had 60-79% stenosis. Having lower degree of stenosis is not protective against stroke and death for either CEA or CAS at either 30 days or 2 years postoperatively. We believe that optimal medical management should be the first line in stroke prevention for asymptomatic patients with severe (60-79%) carotid stenosis.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hicks CW, Nejim B, Aridi HD, et al. Transfemoral Carotid Artery Stents Should Be Used with Caution in Patients with Asymptomatic Carotid Artery Stenosis. Ann Vasc Surg. 2018. PMID: 30339900. doi:10.1016/j.avsg.2018.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。